Clinical Pharmacodynamic Studies with Cilazapril and a Combination of Cilazapril and Propranolol
- 1 January 1991
- journal article
- clinical trial
- Published by Springer Nature in Drugs
- Vol. 41 (1) , 11-17
- https://doi.org/10.2165/00003495-199100411-00004
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Influence of the angiotensin converting enzyme inhibitor cilazapril, the ??-blocker propranolol and their combination on haemodynamics in hypertensionJournal Of Hypertension, 1989
- Interactions between cilazapril and propranolol in man; plasma drug concentrations, hormone and enzyme responses, haemodynamics, agonist dose-effect curves and baroreceptor reflex.British Journal of Clinical Pharmacology, 1988
- Pharmacokinetics of Captopril in Healthy Subjects and in Patients with Cardiovascular DiseasesClinical Pharmacokinetics, 1988
- A method for estimating the potency of angiotensin‐converting enzyme inhibitors in man.British Journal of Clinical Pharmacology, 1987
- Inhibition of angiotensin-I response by cilazapril and its time course in normal volunteers*Clinical Pharmacology & Therapeutics, 1987
- Hemodynamic Responses to Angiotensin I in Normal Volunteers and the Antagonism by the Angiotensin-Converting Enzyme Inhibitor CilazaprilJournal of Cardiovascular Pharmacology, 1987
- CHARACTERIZATION OF ANGIOTENSIN CONVERTING ENZYME BY [H-3] CAPTOPRIL BINDING1986
- Biological Properties of the Angiotensin-Converting Enzyme Inhibitor CilazaprilJournal of Cardiovascular Pharmacology, 1985
- Duration of Action and Short-Term Hormonal Responses to Enalapril (MK 421) in Normal SubjectsJournal of Cardiovascular Pharmacology, 1984
- Enzymes of the Renin-Angiotensin System and their InhibitorsAnnual Review of Biochemistry, 1982